HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.

Abstract
Typical haemolytic uraemic syndrome (STEC-HUS), caused by Shiga toxin (Stx)-producing Escherichia coli (STEC), is a serious, life-threating disease that mainly affects children. Bacteriological and genetic tests are commonly used in the routine laboratory diagnosis of STEC-HUS; however, serological methods have emerged as useful and reliable diagnostic tools, especially when bacterial isolation fails. In this study, we present the results of the serological investigation of 72 paediatric patients suspected for HUS, hospitalized during 2011-2019 at the Department of Pediatrics and Nephrology of Children's Hospitals in Poland. During the routine laboratory investigation STEC strains were isolated only from nine stool samples. However, serological investigations confirmed 45 cases of STEC infections in children with HUS. In this study, 22 (48·9%) paediatric patients were infected by E. coli serotype O26, 11 (24·4%) by serotype O145, 9 (20·0%) by serotype O157, and 3 (6·7%) by E. coli serotype O111. In the majority of these patients, in addition to a high level of IgA, IgG and IgM antibodies to lipopolysaccharide of particular E. coli serotypes, antibodies to recombinant proteins Tir, Stx2b and intimin were detected. Our results confirm that serological tests are useful in the diagnosis of STEC-HUS. SIGNIFICANCE AND IMPACT OF THE STUDY: This study showed that serological analysis greatly complements bacterial isolation and helps in the diagnosis and confirmation of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) infections. Serological tests can be performed to qualify the patient for the typical haemolytic uraemic syndrome (STEC-HUS). In Poland, STEC-HUS in children is mostly caused by the E. coli serotype O26, which indicates that there is an increasing number of non-O157 STEC infections associated with human diseases in Europe.
AuthorsW Rastawicki, K Śmietańska, N Rokosz-Chudziak, T Wołkowicz
JournalLetters in applied microbiology (Lett Appl Microbiol) Vol. 70 Issue 6 Pg. 440-446 (Jun 2020) ISSN: 1472-765X [Electronic] England
PMID32270510 (Publication Type: Journal Article)
Copyright© 2020 The Society for Applied Microbiology.
Chemical References
  • Adhesins, Bacterial
  • Antibodies, Bacterial
  • Escherichia coli Proteins
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Lipopolysaccharides
  • Recombinant Proteins
  • Shiga Toxin
Topics
  • Adhesins, Bacterial (genetics)
  • Antibodies, Bacterial (blood)
  • Antibody Formation
  • Child
  • Child, Preschool
  • Escherichia coli Infections (diagnosis, microbiology)
  • Escherichia coli Proteins (genetics, immunology)
  • Europe
  • Female
  • Hemolytic-Uremic Syndrome (diagnosis, microbiology)
  • Humans
  • Immunoglobulin A (blood)
  • Immunoglobulin G (blood)
  • Immunoglobulin M (blood)
  • Infant
  • Lipopolysaccharides (immunology)
  • Male
  • Poland
  • Recombinant Proteins (genetics)
  • Serogroup
  • Shiga Toxin (genetics, immunology)
  • Shiga-Toxigenic Escherichia coli (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: